Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ECHO vs MRNA✓SelectedUSD · MRNAECHO vs MRNA performance historyLatest closeAs of-2.26%11/18
Stock and ETF performance explorer

ECHO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+813.5%
MRNA return
+156.2%
Excess return
+657.2%
Maximum drawdown
-48.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.3%-4.8%+2.6%-2.1%
7D-5.2%-20.9%+15.7%-4.5%
30D+12.4%-13.3%+25.7%+12.9%
3M+7.7%+212.6%-204.9%+2.6%
6M-29.0%+309.0%-338.0%-34.5%
YTD-10.8%+567.3%-578.1%-22.0%
1Y+39.0%+689.7%-650.7%+19.7%
All+813.5%+156.2%+657.2%+699.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling